| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |